Molecular Health

Guardian Research Network, Molecular Health to expand trial access for cancer patients

Monday, June 1, 2015

The Guardian Research Network, a nationwide consortium of community health systems based in Spartanburg, S.C., and Molecular Health, a biomedical company headquartered in Heidelberg, Germany, have announced a collaboration designed to provide therapeutic clinical trial access and molecular diagnostic decision support to the majority of cancer patients living in U.S. communities.

[Read More]